ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,606, issued on Jan. 13, was assigned to University of Washington (Seattle) and UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington).

"Modified pyrrolo- and pyrazolo-pyrimidines for prostate cancer therapy" was invented by Wesley C. Van Voorhis (Seattle), Dustin James Maly (Seattle), Kayode K. Ojo (Seattle), Gayani Perera (Seattle), Stephen R. Plymate (Seattle), Cynthia Sprenger (Seattle), Takuma Uo (Seattle) and Rama Subba Rao Vidadala (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and c...